Navigating efficiency, compliance and innovation in basic and preclinical (drug) development
Webcode 26112470
Timo Ahland
Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, GERMANY
Data Protection Officer for Germany and Head of the European Data Protection Team Timo Ahland studied law at Ruhr University Bochum and the German University of Administrative Sciences in Speyer. He is admitted to the bar by the Koblenz Higher Regional Court. Prior to his current role as Data Protection Officer, he spent six years as a corporate lawyer, specializing in advising the global corporate procurement and IT departments of the Boehringer Ingelheim Group. Timo Ahland has served as the appointed in-house Data Protection Officer and external Data Protection Officer for the operating companies of the Boehringer Ingelheim Group in Germany (approx. 15,000 employees) and, together with his team supporting the Group Data Protection Officer, oversees the European region with a network of currently approx. 25 regional and local data protection officers and experts. He represents the company in data protection matters before numerous associations at the national level (BDI, VCI, BAVC, and vfa). He regularly serves as a speaker at professional and continuing education events on data protection, with a focus on medical research and drug development.
Christian Mehrmann
cormeo GmbH, Gütersloh, GERMANY
Director Solultion Portfolio
Christian Mehrmann is Director Solution Portfolio at cormeo, where he focuses on advancing pharma-tech solutions for regulated information management, including areas such as structured content authoring, ePI, and Track & Trace.
He brings over 15 years of experience at arvato Systems, where he held roles as Senior Product Manager and Senior Business Analyst, gaining deep expertise in product management, business development, and project management. Prior to that, he worked as Product and Business Development Manager at ROTE LISTE®.
He has further developed his expertise through certifications in Machine Learning and Python.
More information please click here.
Dr. Irina Tihaa
d-fine GmbH, Düsseldorf, GERMANY
Manager
Dr. Irina Tihaa is a Manager at d-fine and drives AI and digital innovation projects for clients in the Pharma & Healthcare sector, focusing on user-centered application of both emerging and established technologies as well as end-to-end processes.
Before joining d-fine, Irina worked at Forschungszentrum Jülich and RWTH Aachen University.
More information please click here.
17/11/2026
17/11/2026
From 09:00 am until 12:30 pm CET
You may dial in 30 minutes before the lecture starts
online
online
Event - 690€ plus tax
The registration fee includes downloadable materials, a certificate, access to the Learning Space, and technical support, including a pre-meeting.
Event - 690€ plus tax
The registration fee includes downloadable materials, a certificate, access to the Learning Space, and technical support, including a pre-meeting.
Dr. Birgit Wessels
Conference Manager
+49 6221 500-652
b.wessels@forum-institut.de
AI in Pharma R&D: During the half-day seminar you will learn how to navigate compliance requirements due to regulatory frameworks, you will explore how structured content enables AI-supported document creation, and how to combine established scientific methods with AI to accelerate drug development in basic and preclinical research.
This seminar offers a timely opportunity to deepen your understanding of artificial intelligence (AI) as it reshapes preclinical drug development.
You, as professional in Pharma R&D, will gain practical knowledge of the latest regulatory frameworks, including the EU AI Act and the joint EMA/FDA principles published in January 2026, equipping you to navigate compliance requirements with confidence.
Furthermore, you will explore how structured content enables AI-supported document creation in regulated environments.
Through real-world project insights, you will learn how to strategically combine established scientific methods with AI and explainable AI (xAI) to uncover mechanisms of action and accelerate drug discovery.
Whether you are evaluating AI adoption or looking to optimise your current approach, this course provides the critical knowledge needed to stay competitive and compliant in a rapidly evolving field.
Upon participation, you will
Welcome, introduction, expectations
Timo Ahland
Christian Mehrmann
Biobreak
Dr Irina Tihaa
You are looking for this topic for several employees?
We offer the right solution at your site or in virtual format!
We also offer this seminar as an in-house seminar.
Take advantage of the proven concepts of our open seminars and bring your employees to the same level of knowledge quickly and easily.
We will be happy to send you a non-binding offer.
You can attend one of our pre-meetings and explore our Learning Space free of charge. Registration is not required. You can find available dates for a pre-meeting in your customer portal. Click the green ‘Participate’ button in the pre-meeting in the customer portal and you will be redirected to the Learning Space.
The pre-meeting gives you the opportunity to explore our Learning Space and to familiarise yourself with the technology to start off your online training on the right foot. This is a non-binding offer for all our customers and not a prerequisite for participation. If a pre-meeting date does not suit you but you would still like a technology check, please contact us.
You need a reliable Internet connection to take part in our online events. To have the best possible learning experience, we recommend that you use the latest version of the Microsoft Edge or Google Chrome browsers. You will need a headset, loudspeaker or telephone to play the audio. Further information is available here. Please check beforehand that your microphone or headset and camera are working properly. Do not access our services from a VPN since there are issues with the audio over such connections.
We have integrated Zoom video conferencing software into our Learning Space for our online training courses. If you are not authorised to use Zoom, please get in touch with us so we can make alternative arrangements for you to take part in our online training.
of 5 stars of all ratings from 2025
of 5 stars on Trustpilot = good
Global regulatory requirements for drug device combination products (DDCs): You will receive a regulatory overview for t...
Are you working in the QPPV Office or are you a Local Safety Officer? This focused online course supports your daily res...
Do you want to independently plan and conduct pharmacovigilance audits? Then take this opportunity to become an "Auditor...
CMC requirements in China, Japan, South Korea, India and Russia/EAEU. Meet our three experts to get an update on the cur...
- Registration open until 21 April 2026. Remaining places subject to availability. - This seminar provides an in-depth e...
